Continuous Glucose Monitoring (CGM) in Long Term Care (LTC) Facilities

Last updated: August 28, 2024
Sponsor: Joslin Diabetes Center
Overall Status: Active - Recruiting

Phase

N/A

Condition

Aging

Diabetic Neuropathy

Hormone Deficiencies

Treatment

N/A

Clinical Study ID

NCT05711108
STUDY00000128
  • Ages > 65
  • All Genders

Study Summary

To prospectively determine the burden of hypoglycemia (minutes spent below 70 mg/dl per day, measured by continuous glucose monitor (CGM)) among residents of long term care facilities (LTC) with a diagnosis of type 1 or type 2 diabetes including key clinical subgroups (living in skilled nursing facility (SNF) or nursing home (NH), on different hypoglycemic medications).

This aim will be achieved by recruiting 300 residents with diabetes in 4 LTC facilities. All participants will undergo masked CGM for 10 days.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Adults >64 years with diagnosis of type 1 or type 2 diabetes

  • Using glucose-lowering medication or insulin

Exclusion

Exclusion Criteria:

  • Currently taking or planning to take hydroxyurea

  • Patient or Health care proxy refuses to sign consent form

Study Design

Total Participants: 300
Study Start date:
January 19, 2022
Estimated Completion Date:
December 31, 2024

Connect with a study center

  • Joslin Diabetes Center

    Boston, Massachusetts 02215
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.